References

AL-BILTAGI, M. A. M., ABO-ELEZZ, A., ABD-ELHAFEZ, M. A., MABROUK, M. M. & SULIMAN, G. A. 2017. Beneficial Effects of Omega-3 Supplement to the Enteral Feeding in Children With Mild to Moderate Sepsis. Journal of Intensive Care Medicine, 32, 212-217.
BORENSTEIN, M., HEDGES, L. V., HIGGINS, J. P. & ROTHSTEIN, H. R. 2010. A basic introduction to fixed‐effect and random‐effects models for meta‐analysis. Research synthesis methods, 1, 97-111.
CALDER, P. C. 2006. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr, 83, 1505s-1519s.
CARCILLO, J. A., PODD, B., ANEJA, R., WEISS, S. L., HALL, M. W., CORNELL, T. T., SHANLEY, T. P., DOUGHTY, L. A. & NGUYEN, T. C. 2017. Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.Pediatr Crit Care Med, 18, S32-s45.
CARR, A. C. & MAGGINI, S. 2017. Vitamin C and Immune Function.Nutrients, 9.
CHEN, Y., ZHOU, Z. Q., YANG, H. H. & LU, H. G. 2017. Effect of omega-3 fatty acids on acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. International Journal of Clinical and Experimental Medicine, 10,15920-15926.
COHEN, D. A., BYHAM-GRAY, L. & DENMARK, R. M. 2013. Impact of two pulmonary enteral formulations on nutritional indices and outcomes.J Hum Nutr Diet, 26, 286-293.
COVAR, R., GLEASON, M., MACOMBER, B., STEWART, L., SZEFLER, P., ENGELHARDT, K., MURPHY, J., LIU, A., WOOD, S., DEMICHELE, S., GELFAND, E. W. & SZEFLER, S. J. 2010. Impact of a novel nutritional formula on asthma control and biomarkers of allergic airway inflammation in children. Clin. Exp. Allergy, 40, 1163-1174.
DAS, U. N. 2013. n-3 fatty acids, gamma-linolenic acid, and antioxidants in sepsis. Crit Care, 17.
DERSIMONIAN, R. & LAIRD, N. 1986. Meta-analysis in clinical trials.Controlled clinical trials, 7, 177-188.
ELAMIN, E. M., HUGHES, L. F. & DREW, D. 2005. Effect of enteral nutrition with eicosapentaenoic acid (EPA), gamma-linoleic acid (GLA), and antioxidants reduces alveolar inflammation mediators and protein influx in patients with acute respiratory distress syndrome (ARDS).Chest, 128, 225S-225S.
ELAMIN, E. M., MILLER, A. C. & ZIAD, S. 2012. Immune Enteral Nutrition Can Improve Outcomes in Medical-Surgical Patients with ARDS: A Prospective Randomized Controlled Trial. J Nutr Disord Ther,2, 109.
GADEK, J. E., DEMICHELE, S., KARLSTAD, M., MURRAY, M., PACHT, E., DONAHOE, M., ALBERTSON, T., VAN HOOZEN, C., WENNBERG, A., NELSON, J. & NOURSALEHI, M. 1998. Enteral nutrition with eicosapentaenoic acid (EPA), γ-linolenic acid (GLA) and antioxidants reduces pulmonary inflammation and new organ failures in patients with Acute Respiratory Distress Syndrome (ARDS). Chest, 114.
GADEK, J. E., DEMICHELE, S. J., KARLSTAD, M. D., PACHT, E. R., DONAHOE, M., ALBERTSON, T. E., VAN HOOZEN, C., WENNBERG, A. K., NELSON, J. L. & NOURSALEHI, M. 1999. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group.Crit Care Med, 27, 1409-20.
GRAU-CARMONA, T., MORAN-GARCIA, V., GARCIA-DE-LORENZO, A., HERAS-DE-LA-CALLE, G., QUESADA-BELLVER, B., LOPEZ-MARTINEZ, J., GONZALEZ-FERNANDEZ, C., MONTEJO-GONZALEZ, J. C., BLESA-MALPICA, A., ALBERT-BONAMUSA, I., BONET-SARIS, A., HERRERO-MESEGUER, J. I., MESEJO, A. & ACOSTA, J. 2011. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma-linolenic acid and anti-oxidants on the outcome of mechanically ventilated, critically ill, septic patients.Clin Nutr, 30, 578-84.
HAMILTON, L. A. & TROBAUGH, K. A. 2011. Acute Respiratory Distress Syndrome: Use of Specialized Nutrients in Pediatric Patients and Infants. Nutrition in Clinical Practice, 26, 26-30.
HEGAZI, R. A. & WISCHMEYER, P. E. 2011. Clinical review: optimizing enteral nutrition for critically ill patients - a simple data-driven formula. Crit Care, 15.
HIGGINS, J., DEEKS, J. & ALTMAN, D. 2011. Special topics in statistics: intention-to-treat issues In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions (version 5.1. 0). Cochrane Collaboration .
HIGGINS, J. P. & ALTMAN, D. G. 2008. Assessing risk of bias in included studies. Cochrane handbook for systematic reviews of interventions: Cochrane book series , 187-241.
HIGGINS, J. P. & THOMPSON, S. G. 2002. Quantifying heterogeneity in a meta‐analysis. Statistics in medicine, 21, 1539-1558.
JACOBS, B. R., NADKARNI, V., GOLDSTEIN, B., CHECCHIA, P., AYAD, O., BEAN, J. & DEMICHELE, S. 2013. Nutritional immunomodulation in critically ill children with acute lung injury: Feasibility and impact on circulating biomarkers. Pediatric Critical Care Medicine,14, e45-e56.
KAGAN, I., COHEN, J., STEIN, M., BENDAVID, I., PINSKER, D., SILVA, V., THEILLA, M., ANBAR, R., LEV, S., GRINEV, M. & SINGER, P. 2015. Preemptive enteral nutrition enriched with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in severe multiple trauma: a prospective, randomized, double-blind study. Intensive Care Med,41, 460-469.
KALANTAR-ZADEH, K., BRAGLIA, A., CHOW, J., KWON, O., KUWAE, N., COLMAN, S., COCKRAM, D. B. & KOPPLE, J. D. 2005. An anti-inflammatory and antioxidant nutritional supplement for hypoalbuminemic hemodialysis patients: A pilot/feasibility study. J Ren Nutr, 15,318-331.
LEMOINE, S. C., BRIGHAM, E. P., WOO, H., HANSON, C. K., MCCORMACK, M. C., KOCH, A., PUTCHA, N. & HANSEL, N. N. 2019. Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD.BMC Pulm Med, 19, 97.
LEV, S. & SINGER, P. 2012. n- 3 fatty acids and γ- linolenic acid supplementation in the nutritional support of ventilated patients with acute lung injury or acute respiratory distress syndrome.